Michael Augenbraun is an Infectious Disease physician affiliated with SUNY Downstate Health Sciences University. OpenAlex indexes 148 publications with 5,014 citations (h-index 34).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
41.6%Statin11.1%Atorvastatin Calcium57%Rosuvastatin Calcium43%Part D<11 patientsCalcium channel blocker8.3%Amlodipine Besylate100%Part D≥13 patients+ 5 more classes in this area
Anti-infectives
23%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.4%Triumeq38%Emtricitabine-Tenofovir Disop32%Descovy30%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor5.4%Tivicay59%Cabenuva41%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
22.1%Biguanide (metformin)9.5%Metformin Hcl100%Part D<11 patientsDPP-4 inhibitor4.3%Januvia100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–2000 per NIH RePORTER. The latest:
- ACUTE HCV INFECTION IN HIV INFECTED &UNINFECTED WOMEN
Suny Downstate Medical Center
FY2000$139,399R01DK056442
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
Annals of Internal Medicine
2022 - Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women
Clinical Infectious Diseases
2019 - Artificial Differences in <i>Clostridium difficile</i> Infection Rates Associated with Disparity in Testing
Emerging infectious diseases
2018 - Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus–coinfected Women
Clinical Infectious Diseases
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Weber, MD
SUNY Downstate Health Sciences University
Howard Crystal, MD
SUNY Downstate Health Sciences University
Ovadia Abulafia, MD
SUNY Downstate Health Sciences University
Moro Salifu, MD
SUNY Downstate Health Sciences University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”